TrialJournal of Korean medical science2019

A Phase III Study to Evaluate the Immunogenicity and Safety of GC1107 (Adult Tetanus Diphtheria Vaccine) in Healthy Adults.

Jacob Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.